High-frequency, low-coverage "false positives" mutations may be true in GS Junior sequencing studies.

Zhiliang Yang1, Guilian Sun2

  • 1Department of Pediatrics, the First Hospital of China Medical University, Shenyang, 110001, China. sizhewujiu@163.com.

Scientific Reports
|October 25, 2017
PubMed
Summary

GS Junior sequencing can produce false positives. Sanger sequencing validation is crucial for mutations with borderline characteristics, especially those over 30% frequency, to ensure accurate results.

Related Concept Videos